Sandrine Larue

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases

Sandrine Larue, Francesco Bombelli, Karine Viala et al. · European Journal of Neurology · 2010 · 84 citations

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial

Richard AC Hughes, Marinos C. Dalakas, Ingemar S. J. Merkies et al. · The Lancet Neurology · 2018 · 69 citations · Full text

Rheumatology, Oral Fingolimod, Ophthalmology +10

Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients

Alain Meyer, Yves Troyanov, Julie Drouin et al. · Arthritis Research & Therapy · 2020 · 67 citations · Full text

Diagnosis of late-onset Pompe disease and other muscle disorders by next-generation sequencing

Sébastien Lévesque, Christiane Auray‐Blais, Elaine Gravel et al. · Orphanet Journal of Rare Diseases · 2016 · 57 citations · Full text